NASA can host a media conference at a pair of p.m. EDT weekday, Oct. 17, to debate choose science investigations and technology demonstrations launching on biochemist Grumman’s twelfth industrial resupply mission for the agency to the International space platform.
Northrop Grumman is targeting Saturday, Nov. 2, at 9:59 a.m., for the launch of its Cygnus orbiter on Associate in Nursing Antares rocket from pad 0A at NASA’s Wallops Flight Facility on Wallops Island, Virginia.
Jennifer Buchli, deputy chief mortal for the International space platform Program Science workplace at NASA’s Johnson area Center in Houston, and Michael Roberts, interim chief mortal for the ISS U.S. National laboratory, can offer an outline of the analysis and technology aboard the Cygnus orbiter.
Also collaborating within the making known are:
- Thomas Krueger, team lead of the ecu area Agency’s Human-Robot Interaction laboratory, can discuss the ANALOG-1 investigation, which is able to check telerobotic operations underneath microgravity conditions aboard the space platform.
- Mike Snyder, founder, member, and Chief Engineer for created In area, can discuss created in Space’s Recycler, which is able to check systems required to employ plastic into 3D printing filament within the microgravity surroundings of the International space platform. The Recycler can utilize compound materials to provide filament that may be transferred to the created in area 3D printer that has operated on the orbiting laboratory since 2016.
- Brian York, man of science of the placental mammal Research-14 investigation, can discuss however the investigation studies the consequences of microgravity on the biological biological time and key organ tissues, together with the colon, heart, lung, liver, excretory organ and neural structure. This investigation advances analysis on the foremost common disease in humans.
- Kathleen Coderre, man of science, can discuss AstroRad, a brand new vest that would defend astronauts’ important organs from deep-space radiation. information gained may additionally aid the event of defending technologies for patients on Earth receiving radiation treatments.
Read More: www.nasa.gov